basal insulin

Lilly posts more positive data on once-weekly insulin prospect

Shortly after a positive data drop for Eli Lilly’s efsitora, the Indianapolis-based company is again padding the case for its weekly insulin prospect.

Fraiser Kansteiner Sep 11, 2024 2:05pm

Lilly posts more positive data on its weekly insulin prospect

Sep 5, 2024 6:45am

Lilly’s weekly insulin hits primary endpoint in 2 pivotal trials

May 16, 2024 6:45am

Novo Nordisk ready to submit once-weekly insulin to FDA

Oct 5, 2022 10:42am

Novo Nordisk's once-weekly insulin hits goals in phase 3 trials

Jul 29, 2022 9:25am